Nomura Holdings’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.99M | Sell |
23,100
-20,600
| -47% | -$3.94M | 0.01% | 796 |
|
|
2026
Q1 | $8.01M | Buy |
+43,700
| New | +$8.05M | 0.02% | 485 |
|
|
2025
Q4 | – | Sell |
-19,000
| Closed | -$2.66M | – | 1904 |
|
|
2025
Q3 | $2.66M | Buy |
+19,000
| New | +$2.57M | ﹤0.01% | 1032 |
|
|
2025
Q2 | – | Sell |
-24,500
| Closed | -$3.35M | – | 1482 |
|
|
2025
Q1 | $3.35M | Sell |
24,500
-25,500
| -51% | -$3.65M | 0.01% | 854 |
|
|
2024
Q4 | $7.65M | Buy |
+50,000
| New | +$8.43M | 0.01% | 614 |
|
|
2024
Q2 | – | Sell |
-12,500
| Closed | -$2.7M | – | 1765 |
|
|
2024
Q1 | $2.7M | Buy |
+12,500
| New | +$2.93M | 0.01% | 825 |
|
|
2022
Q3 | – | Sell |
-4,000
| Closed | -$859K | – | 1691 |
|
|
2022
Q2 | $859K | Sell |
4,000
-18,900
| -83% | -$3.86M | ﹤0.01% | 1000 |
|
|
2022
Q1 | $4.92M | Sell |
22,900
-1,400
| -6% | -$304K | 0.01% | 616 |
|
|
2021
Q4 | $5.84M | Buy |
24,300
+22,900
| +1,636% | +$5.89M | 0.01% | 647 |
|
|
2021
Q3 | $406K | Hold |
1,400
| – | – | ﹤0.01% | 1500 |
|
|
2021
Q2 | $499K | Hold |
1,400
| – | – | ﹤0.01% | 1342 |
|
|
2021
Q1 | $392K | Buy |
+1,400
| New | +$378K | ﹤0.01% | 1436 |
|
|
2019
Q1 | – | Sell |
-14,500
| Closed | -$4.43M | – | 1127 |
|
|
2018
Q4 | $4.43M | Hold |
14,500
| – | – | 0.02% | 539 |
|
|
2018
Q3 | $5.09M | Hold |
14,500
| – | – | 0.02% | 490 |
|
|
2018
Q2 | $4.21M | Sell |
14,500
-5,000
| -26% | -$1.41M | 0.01% | 546 |
|
|
2018
Q1 | $5.35M | Hold |
19,500
| – | – | 0.01% | 545 |
|
|
2017
Q4 | $6.22M | Sell |
19,500
-5,000
| -20% | -$1.6M | 0.01% | 564 |
|
|
2017
Q3 | $7.69M | Hold |
24,500
| – | – | 0.02% | 454 |
|
|
2017
Q2 | $6.58M | Sell |
24,500
-15,400
| -39% | -$4.07M | 0.02% | 464 |
|
|
2017
Q1 | $10.9M | Sell |
39,900
-28,700
| -42% | -$8.11M | 0.03% | 273 |
|
|
2016
Q4 | $19.6M | Buy |
68,600
+66,600
| +3,330% | +$19.7M | 0.05% | 229 |
|
|
2016
Q3 | $620K | Hold |
2,000
| – | – | ﹤0.01% | 859 |
|
|
2016
Q2 | $480K | Hold |
2,000
| – | – | ﹤0.01% | 871 |
|
|
2016
Q1 | $515K | Buy |
+2,000
| New | +$528K | ﹤0.01% | 869 |
|
|
2015
Q1 | – | Sell |
-15,900
| Closed | -$5.39M | – | 1784 |
|
|
2014
Q4 | $5.39M | Sell |
15,900
-100
| -0.6% | -$32.4K | 0.01% | 564 |
|
|
2014
Q3 | $5.28M | Buy |
16,000
+6,000
| +60% | +$1.98M | 0.01% | 665 |
|
|
2014
Q2 | $3.21M | Hold |
10,000
| – | – | ﹤0.01% | 885 |
|
|
2014
Q1 | $3.12M | Buy |
+10,000
| New | +$3.17M | ﹤0.01% | 954 |
|
Other funds holding BIIB
Nomura Holdings's BIIB Position: Q2 2026 in Review
Nomura Holdings reduced its Biogen (BIIB) stake by 8.5% in Q2 2026, selling an estimated $273K and leaving 15,305 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #925.
Nomura Holdings first reported a position in BIIB in Q2 2013 and has held it in 48 quarters since. The position peaked at $49.5M in Q3 2019. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Nomura Holdings held 15,305 shares of Biogen worth $3.31M as of Q2 2026.
- Nomura Holdings sold 1,425 Biogen shares in Q2 2026, an estimated $273K.
- Biogen made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #925 holding.
- Nomura Holdings first reported a position in Biogen in Q2 2013 and has held it in 48 quarters since.
- Nomura Holdings's Biogen position peaked at $49.5M in Q3 2019.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.